Sign in

CIK 0000875320 · Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
043039129
Phone
6173416393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,307,135
in 1 filing, $6.3M under 10b5-1 plans

Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kewalramani Reshma −$6.3M CEO & President sold 12% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-22 Ambrose Kristen SVP & Chief Accounting Officer Grant or award +2,950 10,795
2026-01-22 Ambrose Kristen SVP & Chief Accounting Officer Grant or award +1,300 12,095
2026-01-22 WAGNER CHARLES F JR EVP, CO & FO Grant or award +9,440 47,165
2026-01-22 WAGNER CHARLES F JR EVP, CO & FO Grant or award +4,160 51,325
2026-01-22 Tatsis Ourania EVP, Chief Reg. & Quality Off. Grant or award +7,866 50,159
2026-01-22 Tatsis Ourania EVP, Chief Reg. & Quality Off. Grant or award +3,883 54,042
2026-01-22 Sachdev Amit EVP Chief Patient & Ext Af Off Grant or award +7,866 67,115
2026-01-22 Sachdev Amit EVP Chief Patient & Ext Af Off Grant or award +3,883 70,998
2026-01-22 McKechnie Duncan EVP, Chief Commercial Officer Grant or award +4,720 20,858
2026-01-22 McKechnie Duncan EVP, Chief Commercial Officer Grant or award +2,080 22,938
2026-01-22 LEIDEN JEFFREY M Executive Chairman Grant or award +9,012 33,039
2026-01-22 Kewalramani Reshma CEO & President Grant or award +26,972 142,940
2026-01-22 Kewalramani Reshma CEO & President Grant or award +11,885 154,825
2026-01-22 Bozic Carmen EVP and CMO Grant or award +7,866 40,535
2026-01-22 Bozic Carmen EVP and CMO Grant or award +3,467 44,002
2026-01-22 Biller Jonathan EVP and Chief Legal Officer Grant or award +6,294 21,600
2026-01-22 Biller Jonathan EVP and Chief Legal Officer Grant or award +2,774 24,374
2026-01-22 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Grant or award +3,934 20,786
2026-01-22 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Grant or award +3,883 24,669
2026-01-22 ALTSHULER DAVID EVP, Chief Scientific Officer Grant or award +7,866 31,149

Page 9 of 10 · 182 trades